KYAN Therapeutics

Singapore, Singapore

KYAN Therapeutics is a clinical-stage AI company leveraging its proprietary technology platforms to transform the way patients are treated.

May 2024

Grant

Artificial Intelligence (AI)Biopharma Biotechnology Health Care Life Science

Top Investors

Altara VenturesK3Seeds CapitalCedars-Sinai Accelerator

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about KYAN Therapeutics

Who are KYAN Therapeutics's investors?

KYAN Therapeutics's investors include Altara Ventures, K3, Seeds Capital, Cedars-Sinai Accelerator.

Where is KYAN Therapeutics headquartered?

KYAN Therapeutics is headquartered in Singapore, Singapore.

What does KYAN Therapeutics do?

KYAN Therapeutics is a clinical-stage AI company leveraging its proprietary technology platforms to transform the way patients are treated.

What stage is KYAN Therapeutics at?

KYAN Therapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 1, 2024.

MLA

"KYAN Therapeutics — Funding & Investors." VCBacked, May 1, 2024, https://www.vcbacked.co/company/kyan-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2024). KYAN Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/kyan-therapeutics

Wikipedia (cite web)

{{cite web |title=KYAN Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/kyan-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 1, 2024.

Similar Companies in Artificial Intelligence (AI)